Incyte JAK Inhibitor Shows Promising One-Month Data In Rheumatoid Arthritis
This article was originally published in The Pink Sheet Daily
Executive Summary
Phase IIb RA studies launch later this year; myelofibrosis update set for December ASH meeting.